retatrutide trial results october 2025 TRIUMPH-1 Results: for Obesity Lilly's Retatrutide Scores Triple Trial

And 23.7% of subjects in the trial achieved weight loss exceeding 35% of body weight, the highest numbers ever recorded in any obesity trial

It promotes energy production by transporting long-chain fatty acids to the mitochondrial matrix for -oxidation

It is identified in the clinical-research literature under the development designation LY3437943 and is currently in Phase 3 evaluation under the TRIUMPH trial program

Anticancer Res 37:64976509

The results showed that compared with the RBITC-GLP-1RAs@NPs group, the fluorescence intensity in the kidney was lower on the first day in the rats injected with RBITC-GLP-1RAs@NPs-WYRGRL, while the fluorescence intensity in the lower limb joints was significantly increased

Consult Your Doctor Always consult your doctor for recommended medical advice before using this product